Specific inhibitors of urokinase plasminogen activator for treatment of cancers; in silico approach

HIGHLIGHTS

• who: from the a Department of Urology, The University of Toledo, Health Science Campus, Arlington Ave [, ]Toledo, OH, USA, and b M.D. Candidate, Class of, The University of Toledo Heath Science Campus, Arlington Ave., Toledo, OH, USA. have published the research: Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach, in the Journal: (JOURNAL)
• what: Each simulation presented in this paper was run ten times and only results having consistently small and negligible differences were accepted and presented . This work provides evidence that it is possible to find highly specific . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.